VolitionRx Limited Announces Pricing Of $16.5M Public Offering At $1.27/Share
Portfolio Pulse from Benzinga Newsdesk
VolitionRx Limited has announced the pricing of its $16.5 million public offering at $1.27 per share. The company plans to use the proceeds for general corporate purposes.
June 01, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
VolitionRx Limited's stock price may be impacted by the announcement of its $16.5 million public offering at $1.27 per share.
The announcement of a public offering can have mixed effects on a company's stock price. In this case, the offering is priced at $1.27 per share, which may lead to dilution of existing shares. However, the proceeds will be used for general corporate purposes, which could benefit the company in the long run. As a result, the short-term impact on the stock price is uncertain, and a neutral score is assigned.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100